Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. REDDYS LAB BIOCON /
DR. REDDYS LAB
 
P/E (TTM) x 36.7 24.1 152.2% View Chart
P/BV x 4.6 3.7 123.4% View Chart
Dividend Yield % 0.2 0.7 22.6%  

Financials

 BIOCON    DR. REDDYS LAB
EQUITY SHARE DATA
    BIOCON
Mar-22
DR. REDDYS LAB
Mar-22
BIOCON /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4245,614 7.6%   
Low Rs3153,655 8.6%   
Sales per share (Unadj.) Rs68.21,294.6 5.3%  
Earnings per share (Unadj.) Rs8.2126.9 6.4%  
Cash flow per share (Unadj.) Rs14.9196.9 7.6%  
Dividends per share (Unadj.) Rs0.5030.00 1.7%  
Avg Dividend yield %0.10.6 20.9%  
Book value per share (Unadj.) Rs68.51,145.8 6.0%  
Shares outstanding (eoy) m1,200.60166.43 721.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.43.6 151.4%   
Avg P/E ratio x45.336.5 124.2%  
P/CF ratio (eoy) x24.723.5 105.2%  
Price / Book Value ratio x5.44.0 133.3%  
Dividend payout %6.123.6 26.0%   
Avg Mkt Cap Rs m443,622771,272 57.5%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80138,858 48.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840215,452 38.0%  
Other income Rs m6,8914,847 142.2%   
Total revenues Rs m88,731220,299 40.3%   
Gross profit Rs m13,82737,674 36.7%  
Depreciation Rs m8,14211,652 69.9%   
Interest Rs m676958 70.6%   
Profit before tax Rs m11,90029,911 39.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1158,789 24.1%   
Profit after tax Rs m9,78521,122 46.3%  
Gross profit margin %16.917.5 96.6%  
Effective tax rate %17.829.4 60.5%   
Net profit margin %12.09.8 122.0%  
BALANCE SHEET DATA
Current assets Rs m83,823177,880 47.1%   
Current liabilities Rs m38,28097,658 39.2%   
Net working cap to sales %55.637.2 149.5%  
Current ratio x2.21.8 120.2%  
Inventory Days Days10156 180.6%  
Debtors Days Days92113 81.2%  
Net fixed assets Rs m117,184106,819 109.7%   
Share capital Rs m6,003832 721.5%   
"Free" reserves Rs m76,281189,859 40.2%   
Net worth Rs m82,284190,691 43.2%   
Long term debt Rs m39,9855,746 695.9%   
Total assets Rs m201,007284,699 70.6%  
Interest coverage x18.632.2 57.7%   
Debt to equity ratio x0.50 1,612.7%  
Sales to assets ratio x0.40.8 53.8%   
Return on assets %5.27.8 67.1%  
Return on equity %11.911.1 107.4%  
Return on capital %10.315.7 65.5%  
Exports to sales %047.1 0.0%   
Imports to sales %7.818.8 41.4%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs m6,36040,401 15.7%   
Fx inflow Rs m8,885101,544 8.7%   
Fx outflow Rs m6,36040,401 15.7%   
Net fx Rs m2,52561,143 4.1%   
CASH FLOW
From Operations Rs m11,76628,108 41.9%  
From Investments Rs m-16,991-26,387 64.4%  
From Financial Activity Rs m2,421-2,422 -100.0%  
Net Cashflow Rs m-2,43332 -7,603.1%  

Share Holding

Indian Promoters % 39.7 26.7 148.7%  
Foreign collaborators % 20.9 0.0 -  
Indian inst/Mut Fund % 24.0 51.1 47.1%  
FIIs % 16.3 25.9 63.0%  
ADR/GDR % 0.0 10.4 -  
Free float % 39.4 62.9 62.6%  
Shareholders   341,016 255,300 133.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Indian Share Markets End Flat; IT and FMCG Stocks Witness Selling(Closing)

Indian share markets traded in a rangebound manner throughout the day to end on a flat note.